|
|
|
Volumn , Issue , 2006, Pages
|
|
Comparison of schizophrenia drugs often favors firm funding study.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROLEPTIC AGENT;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG INDUSTRY;
ECONOMICS;
EMPIRICAL APPROACH;
FINANCIAL MANAGEMENT;
HUMAN;
MENTAL HEALTH THERAPIES;
METHODOLOGY;
POPULAR APPROACH/SOURCE;
PUBLISHING;
SCHIZOPHRENIA;
STATISTICS;
TREATMENT OUTCOME;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EMPIRICAL APPROACH;
MENTAL HEALTH THERAPIES;
POPULAR APPROACH/SOURCE;
ANTIPSYCHOTIC AGENTS;
CLINICAL TRIALS;
DRUG INDUSTRY;
HUMANS;
PUBLICATION BIAS;
RESEARCH DESIGN;
RESEARCH SUPPORT;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
|
EID: 33747463987
PISSN: 01908286
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
